Takeda’s Phase III CMV infection trial of Livtencity meets primary goal
In the trial, 55.7% of patients in the Livtencity arm attained CMV DNA level below the LLOQ by week eight.
Japan
Latest in
Japan
Longeveron to explore cell-based therapy in trial of older and frail subjects
Lomecel-B has been assessed in Phase I and II clinical studies in the US for ageing frailty.
Daiichi Sankyo doses first subject in Phase III breast cancer therapy trial
The trial will assess the safety and efficacy of Enhertu as a neoadjuvant therapy for breast cancer patients.
Revealed: the pharma companies leading the way in artificial intelligence
Novartis and Johnson & Johnson are among the companies best positioned to take advantage of future AI disruption.
By
Science 37 and CMIC collaborate for decentralised clinical trials
The decentralisation of clinical studies helps to reduce costs, improve efficiency and allow more patients to participate.
Aerie reports positive Phase III data for netarsudil ophthalmic solution
Conjunctival hyperemia was the most common treatment-emergent adverse event reported in the trial.
MEI Pharma and Kyowa Kirin start dosing in Phase III lymphoma trial
Data from the trial is expected to support marketing applications in the US and other countries for zandelisib in this…
Healios reports positive data of cell therapy in ARDS patients
The stem cell regenerative therapy is expected to become the first drug used for ARDS, which has no direct treatment…